A Biotechnology Firm
Leading The Translational Glycobiology Research
Who We Are/Our Interest
We are a start up biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer and infectious disease. Animal cell surfaces are covered with carbohydrates and proteins. These components mediate interactions between two cells or between the cell and the extra-cellular matrix components. These protein-carbohydrate interactions mediate various biological processes such as cell activation, growth regulation, apoptosis, and cancer metastasis. Infection of cells with bacteria or viruses is also mediated through protein-carbohydrate interactions.